BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12570661)

  • 1. The prodigiosins: a new family of anticancer drugs.
    Montaner B; Pérez-Tomás R
    Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the antitumoral properties of prodiginines.
    Pérez-Tomás R; Viñas M
    Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prodigiosins, proapoptotic drugs with anticancer properties.
    Pérez-Tomás R; Montaner B; Llagostera E; Soto-Cerrato V
    Biochem Pharmacol; 2003 Oct; 66(8):1447-52. PubMed ID: 14555220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodigiosins as anti cancer agents: living upto their name.
    Pandey R; Chander R; Sainis KB
    Curr Pharm Des; 2009; 15(7):732-41. PubMed ID: 19275639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and immunosuppressive activity of novel prodigiosin derivatives.
    D'Alessio R; Bargiotti A; Carlini O; Colotta F; Ferrari M; Gnocchi P; Isetta A; Mongelli N; Motta P; Rossi A; Rossi M; Tibolla M; Vanotti E
    J Med Chem; 2000 Jun; 43(13):2557-65. PubMed ID: 10891115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
    Manderville RA
    Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties and applications of undecylprodigiosin and other bacterial prodigiosins.
    Stankovic N; Senerovic L; Ilic-Tomic T; Vasiljevic B; Nikodinovic-Runic J
    Appl Microbiol Biotechnol; 2014 May; 98(9):3841-58. PubMed ID: 24562326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the a-ring on the proton affinity and anticancer properties of the prodigiosins.
    Melvin MS; Tomlinson JT; Park G; Day CS; Saluta GR; Kucera GL; Manderville RA
    Chem Res Toxicol; 2002 May; 15(5):734-41. PubMed ID: 12018996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of natural anti-tumor drugs by microorganisms.
    Chang CC; Chen WC; Ho TF; Wu HS; Wei YH
    J Biosci Bioeng; 2011 May; 111(5):501-11. PubMed ID: 21277252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
    Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
    Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov.
    Liu R; Cui CB; Duan L; Gu QQ; Zhu WM
    Arch Pharm Res; 2005 Dec; 28(12):1341-4. PubMed ID: 16392666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
    Soto-Cerrato V; Llagostera E; Montaner B; Scheffer GL; Perez-Tomas R
    Biochem Pharmacol; 2004 Oct; 68(7):1345-52. PubMed ID: 15345324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodigiosin and its potential applications.
    Darshan N; Manonmani HK
    J Food Sci Technol; 2015 Sep; 52(9):5393-407. PubMed ID: 26344956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
    Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
    Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
    La JQ; Michaelides AA; Manderville RA
    J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a prodigiosin cyclization gene in the roseophilin producer and production of a new cyclized prodigiosin in a heterologous host.
    Kimata S; Izawa M; Kawasaki T; Hayakawa Y
    J Antibiot (Tokyo); 2017 Feb; 70(2):196-199. PubMed ID: 27460763
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by gamma-proteobacterium, using stratum corneum epidermis of the Yucatan micropig.
    Nakashima T; Kato Y; Yamaguchi K; Oda T
    J Infect Chemother; 2005 Jun; 11(3):123-8. PubMed ID: 15990975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome.
    Liu P; Wang YY; Qi X; Gu Q; Geng M; Li J
    PLoS One; 2013; 8(6):e65381. PubMed ID: 23799011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years.
    Fürstner A
    Angew Chem Int Ed Engl; 2003 Aug; 42(31):3582-603. PubMed ID: 12916029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anion transporters and biological systems.
    Gale PA; Pérez-Tomás R; Quesada R
    Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.